SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-531450
Filing Date
2016-04-06
Accepted
2016-04-06 07:10:02
Documents
8
Period of Report
2016-04-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d147828d8k.htm 8-K 14331
2 EX-99.1 d147828dex991.htm EX-99.1 18379
3 EX-99.2 d147828dex992.htm EX-99.2 8848
4 EX-99.3 d147828dex993.htm EX-99.3 9094
5 EX-99.4 d147828dex994.htm EX-99.4 9986
6 GRAPHIC g147828ex992.jpg GRAPHIC 192514
7 GRAPHIC g147828ex993.jpg GRAPHIC 173115
8 GRAPHIC g147828ex994.jpg GRAPHIC 195108
  Complete submission text file 0001193125-16-531450.txt   834164
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 161556519
SIC: 2834 Pharmaceutical Preparations